LifeStance Health Group, Inc. — Form 8-K Summary
Business Context and Reporting Period
LifeStance Health Group, Inc. filed this Current Report on May 10, 2023, under Items 2.02, 7.01, and 9.01. The filing relates to the Company’s results of operations for the first quarter ended March 31, 2023.
Financial Results and Key Metrics
The filing states that LifeStance issued a press release announcing its first-quarter 2023 results and furnished a supplemental slide presentation. The provided filing text does not include clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, operating statistics, or other financial metrics.
Material Changes Versus the Prior Comparable Period
The filing text does not provide comparative financial results or a clear discussion of changes versus the first quarter of 2022.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not include guidance, outlook commentary, risk updates, contingencies, or unusual items. These matters may be addressed in the furnished press release or slide presentation, which are referenced as Exhibits 99.1 and 99.2 but are not included in the provided text.
The information furnished under Items 2.02 and 7.01, including the exhibits, is not deemed filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other SEC filings unless expressly stated.
Investor Verification Items
- Review Exhibit 99.1 for first-quarter 2023 revenue, earnings, cash flow, margins, operating metrics, and management commentary.
- Review Exhibit 99.2 for supplemental performance information, guidance, and outlook.
- Verify any year-over-year changes, liquidity position, debt balances, and non-GAAP measures directly against the underlying exhibits.
- Note that the provided filing text identifies the results announcement but does not itself state the underlying financial amounts.